Change of Adviser

For immediate release: 19 March 2010

Akers Biosciences, Inc.

(the "Company")

Change of Adviser

Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce the appointment of Daniel Stewart & Company plc as Nominated Adviser and Broker to the Company with immediate effect.

Enquiries:

Thomas A. Nicolette

President and CEO

Tel. +1 856 848 8698

Ben Simons

M: Communications

Tel. +44 (0)20 7920 2340

Emma Earl or Simon Leathers

Daniel Stewart & Co.

Tel. +44 (0)20 7776 6550